C81.99
Hodgkin lymphoma, unspecified, extranodal and solid organ sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Hodgkin lymphoma is a type of cancer that originates from lymphocytes, a subset of white blood cells involved in the immune response. When diagnosed as unspecified with extranodal and solid organ involvement (ICD-10 Code C81.99), it indicates the disease has spread beyond the traditional lymph nodes to other parts of the body such as organs. This condition requires precise diagnosis and careful management to effectively address the disease's spread and impact.
Causes & Symptoms
Clinical Causes: Genetic factors may increase susceptibility to Hodgkin lymphoma. Previous infections with Epstein-Barr virus (EBV) are associated with higher risk. Family history of lymphomas or related cancers can be a risk factor. Weakened immune system due to HIV/AIDS, certain medications, or immunodeficiency disorders. Environmental exposures, although less clearly linked, may contribute in some cases.
Key Symptoms: Swollen lymph nodes in the neck, armpits, or groin that are usually painless. Unexplained fever and night sweats. Unintentional weight loss. Itching skin without a clear cause. Persistent fatigue or weakness. Pain or discomfort in affected areas, especially after consuming alcohol. Symptoms related to extranodal spread can include coughing, difficulty swallowing, or abdominal pain depending on the organ involved. Enlargement of organs such as liver or spleen, which may cause a sensation of fullness or discomfort.
Diagnostic & Treatment
Diagnosis Path: The diagnostic process typically involves several steps to confirm Hodgkin lymphoma and determine its extent. These include: - Physical exam and medical history assessment. - Imaging tests like CT scans, PET scans, or MRI to identify affected areas and extranodal involvement. - Biopsy of affected lymph nodes or tissues to identify Reed-Sternberg cells, characteristic of Hodgkin lymphoma. - Laboratory tests such as blood counts and organ function tests to assess overall health. - Additional tests to evaluate the spread to solid organs, which may involve biopsy or imaging.
Treatment Protocols: Treatment strategies for Hodgkin lymphoma with extranodal and solid organ involvement are tailored to individual cases. Common approaches include: - Chemotherapy to destroy cancer cells. - Radiation therapy targeted at affected areas. - Targeted therapies or immunotherapies that boost the immune system's ability to fight the disease. - Stem cell or bone marrow transplants in advanced cases. Management of symptoms and supportive care are also important components, often involving medications for pain relief, infection prevention, and addressing organ-specific issues. The treatment plan is developed by a multidisciplinary team specializing in lymphoma care.
Clinical Advice & FAQs
Billing Guidance
Is C81.99 a billable ICD-10 code?
Yes, C81.99 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.99?
Clinical documentation must specify the nature of Hodgkin lymphoma, unspecified, extranodal and solid organ sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference